睾酮缺乏与前列腺癌：对一种重要且棘手关系的新认识。 - Suppr

Suppr

超能文献

Testosterone deficiency and prostate cancer: emerging recognition of an important and troubling relationship.

作者信息

Morgentaler Abraham

出版信息

Eur Urol. 2007 Sep;52(3):623-5. doi: 10.1016/j.eururo.2007.04.005. Epub 2007 Apr 9.

DOI:10.1016/j.eururo.2007.04.005

PMID:17433531

Abstract

摘要

相似文献

Testosterone deficiency and prostate cancer: emerging recognition of an important and troubling relationship.

Eur Urol. 2007 Sep;52(3):623-5. doi: 10.1016/j.eururo.2007.04.005. Epub 2007 Apr 9.

Low pretreatment total testosterone (< 3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancer.

BJU Int. 2011 May;107(9):1400-3. doi: 10.1111/j.1464-410X.2010.09816.x. Epub 2010 Nov 2.

Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.

J Urol. 2007 Oct;178(4 Pt 1):1290-5. doi: 10.1016/j.juro.2007.05.129. Epub 2007 Aug 14.

Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.

J Urol. 2007 Oct;178(4 Pt 1):1249-52. doi: 10.1016/j.juro.2007.05.151. Epub 2007 Aug 14.

Prognostic significance of thymidylate synthase expression in patients with prostate cancer undergoing radical prostatectomy.

Urology. 2007 May;69(5):988-95. doi: 10.1016/j.urology.2007.02.015.

Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.

J Urol. 2007 Oct;178(4 Pt 1):1277-80; discussion 1280-1. doi: 10.1016/j.juro.2007.05.153. Epub 2007 Aug 14.

[Radical perineal prostatectomy].

Aktuelle Urol. 2008 Sep;39(5):381-94. doi: 10.1055/s-2005-873228. Epub 2008 Sep 16.

Influence of body mass index and total testosterone level on biochemical recurrence following radical prostatectomy.

Jpn J Clin Oncol. 2008 Feb;38(2):129-33. doi: 10.1093/jjco/hym162. Epub 2008 Feb 14.

Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.

J Urol. 2007 Nov;178(5):1957-62; discussion 1962. doi: 10.1016/j.juro.2007.07.043. Epub 2007 Sep 17.

The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy.

J Urol. 2007 Oct;178(4 Pt 1):1306-10. doi: 10.1016/j.juro.2007.05.159. Epub 2007 Aug 14.

引用本文的文献

Low free and bioavailable testosterone levels may predict pathologically-proven high-risk prostate cancer: a prospective, clinical trial.

Turk J Urol. 2017 Sep;43(3):289-296. doi: 10.5152/tud.2017.35467. Epub 2017 Aug 1.

Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result.

Int Braz J Urol. 2016 Sep-Oct;42(5):925-931. doi: 10.1590/S1677-5538.IBJU.2015.0167.

Prostate size and adverse pathologic features in men undergoing radical prostatectomy.

Urology. 2014 Jul;84(1):153-7. doi: 10.1016/j.urology.2014.04.006.

When and when not to use testosterone for palliation in cancer care.

Curr Oncol Rep. 2014 Apr;16(4):378. doi: 10.1007/s11912-014-0378-0.

Testosterone deficiency: a historical perspective.

Asian J Androl. 2014 Mar-Apr;16(2):161-8. doi: 10.4103/1008-682X.122358.

Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy.

World J Urol. 2012 Jun;30(3):361-5. doi: 10.1007/s00345-011-0741-9. Epub 2011 Aug 11.

Differing levels of testosterone and the prostate: a physiological interplay.

Nat Rev Urol. 2011 May 31;8(7):365-77. doi: 10.1038/nrurol.2011.79.

Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml.

Korean J Urol. 2010 Dec;51(12):831-5. doi: 10.4111/kju.2010.51.12.831. Epub 2010 Dec 21.

Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillance.

Prostate Cancer Prostatic Dis. 2011 Mar;14(1):53-7. doi: 10.1038/pcan.2010.36. Epub 2010 Oct 12.

[Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth].

Urologe A. 2009 May;48(5):516-22. doi: 10.1007/s00120-009-1954-z.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验